Cytogel Pharma is a biopharmaceutical company developing treatments to resolve pain with substantially reduced side effects. The company develops drug candidates from the novel endomorphin family of molecules that target key pain pathways and alleviate pain. This approach is backed by scientific evidence that elucidates its mechanism of action,